UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults

Clinical immunology (Orlando, Fla.), 2021-08, Vol.229, p.108782-108782, Article 108782

2021

Volltextzugriff (PDF)

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

PloS one, 2013-07, Vol.8 (7), p.e70409-e70409

2013

Volltextzugriff (PDF)

Development of T cell immunity to norovirus and rotavirus in children under five years of age

Scientific reports, 2019-03, Vol.9 (1), p.3199-3199, Article 3199

2019

Volltextzugriff (PDF)

Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform

Archives of virology, 2021-01, Vol.166 (1), p.213-217

2021

Volltextzugriff (PDF)

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens

Clinical immunology (Orlando, Fla.), 2018-12, Vol.197, p.110-117

2018

Volltextzugriff (PDF)

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

Frontiers in microbiology, 2016-10, Vol.7, p.1570-1570

2016

Volltextzugriff (PDF)

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization

Viruses, 2019-11, Vol.11 (11), p.1018

2019

Volltextzugriff (PDF)

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

Viruses, 2019-01, Vol.11 (2), p.91

2019

Volltextzugriff (PDF)

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

Journal of Immunology Research, 2020, Vol.2020 (2020), p.1-14

2020

Volltextzugriff (PDF)

Identification of a First Human Norovirus CD8+ T Cell Epitope Restricted to HLA-A0201 Allele

Frontiers in immunology, 2018-11, Vol.9, p.2782-2782

2018

Volltextzugriff (PDF)

SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion

Frontiers in cellular and infection microbiology, 2023-06, Vol.13, p.1216364-1216364

2023

Volltextzugriff (PDF)

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-13

2016

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Frontiers in immunology, 2022-10, Vol.13, p.1021500

2022

Volltextzugriff (PDF)

Modular vaccine platform based on the norovirus-like particle

Journal of nanobiotechnology, 2021-01, Vol.19 (1), p.25-25, Article 25

2021

Volltextzugriff (PDF)

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

Human vaccines & immunotherapeutics, 2016-03, Vol.12 (3), p.740-748

2016

Volltextzugriff (PDF)

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana

Pharmaceutics, 2019-05, Vol.11 (5), p.229

2019

Volltextzugriff (PDF)

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

Vaccines (Basel), 2021-07, Vol.9 (7), p.733

2021

Volltextzugriff (PDF)

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice

Journal of Immunology Research, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

Vaccines (Basel), 2020-07, Vol.8 (3), p.365

2020

Volltextzugriff (PDF)

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

Journal of virological methods, 2012-01, Vol.179 (1), p.1-7

2012

Volltextzugriff (PDF)

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

Vaccine, 2011-10, Vol.29 (45), p.8126-8133

2011

Volltextzugriff (PDF)

High Serum Levels of Norovirus Genotype-Specific Blocking Antibodies Correlate With Protection From Infection in Children

The Journal of infectious diseases, 2014-12, Vol.210 (11), p.1755-1762

2014

Volltextzugriff (PDF)

Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins

Archives of virology, 2016-11, Vol.161 (11), p.3219-3223

2016

Volltextzugriff (PDF)

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

Journal of medical virology, 2015-10, Vol.87 (10), p.1656-1661

2015

Volltextzugriff (PDF)

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

Antiviral research, 2018-09, Vol.157, p.1-8

2018

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

Development of T cell immunity to norovirus and rotavirus in children under five years of age

Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

Identification of a First Human Norovirus CD8+ T Cell Epitope Restricted to HLA-A0201 Allele

SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Modular vaccine platform based on the norovirus-like particle

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

High Serum Levels of Norovirus Genotype-Specific Blocking Antibodies Correlate With Protection From Infection in Children

Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

Suchergebnisse filtern